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Background. Sputum microscopy and culture are commonly used for diagnosing the cause of pneumonia in adults but are 
rarely performed in children due to difficulties in obtaining specimens. Induced sputum is occasionally used to investigate lower 
respiratory infections in children but has not been widely used in pneumonia etiology studies.
Methods. We evaluated the diagnostic utility of induced sputum microscopy and culture in patients enrolled in the Pneumonia Etiology 
Research for Child Health (PERCH) study, a large study of community-acquired pneumonia in children aged 1–59 months. Comparisons 
were made between induced sputum samples from hospitalized children with radiographically confirmed pneumonia and children cate-
gorized as nonpneumonia (due to the absence of prespecified clinical and laboratory signs and absence of infiltrate on chest radiograph).
Results. One induced sputum sample was available for analysis from 3772 (89.1%) of 4232 suspected pneumonia cases enrolled 
in PERCH. Of these, sputum from 2608 (69.1%) met the quality criterion of <10 squamous epithelial cells per low-power field, and 
1162 (44.6%) had radiographic pneumonia. Induced sputum microscopy and culture results were not associated with radiographic 
pneumonia, regardless of prior antibiotic use, stratification by specific bacteria, or interpretative criteria used.
Conclusions. The findings of this study do not support the culture of induced sputum specimens as a diagnostic tool for pneu-
monia in young children as part of routine clinical practice.
Keywords. pneumonia; induced sputum; culture; microscopy; children.
 
Microscopy and culture of sputum specimens are standard 
techniques commonly used by diagnostic laboratories to evalu-
ate pneumonia in adults. Despite difficulties interpreting results 
[1], carefully collected and processed sputum specimens have 
been shown to be useful diagnostic tools in some contexts [2]. 
Nonetheless, ongoing controversy continues about the value 
of routinely examining sputum [3–7]. Furthermore, sputum 
microscopy and culture are not routinely performed in chil-
dren, who are typically unable to expectorate, making it difficult 
to obtain specimens [8].
Induced sputum is widely used to investigate lower respira-
tory infections in immunocompromised adults, especially for 
diagnosing Pneumocystis jirovecii infection [9]. It has also 
been used to diagnose pneumonia in children from settings 
with a high prevalence of tuberculosis [10]. However, few 
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studies have collected induced sputum routinely from chil-
dren with pneumonia. Recent studies of children hospitalized 
with community-acquired pneumonia from Finland, Kenya, 
and New Caledonia showed that collection of induced spu-
tum was well tolerated, with a diagnostic yield from culture 
ranging from 12% to 65% using different interpretative crite-
ria [11–14].
We made a decision to include microscopy and culture of 
induced sputum as part of the Pneumonia Etiology Research 
for Child Health (PERCH) study, a large case-control study 
involving 9 sites in 7 countries from sub-Saharan Africa and 
south Asia [15, 16]. The expectation was that this approach may 
help overcome the inherent difficulties with obtaining speci-
mens from the lower respiratory tract in children with pneu-
monia and facilitate the diagnosis of pneumonia etiology. In an 
accompanying article we show that low numbers of squamous 
epithelial cells (SECs) was the best measure of induced sputum 
quality in children with pneumonia from the PERCH study, 
as evidenced by low quantities of oropharyngeal flora and 
higher prevalence of putative pathogens. A  large proportion 
of induced sputum samples met this criterion for good qual-
ity, suggesting that most specimens originated from the lower 
respiratory tract [17]. Here, we evaluate the diagnostic utility 
of induced sputum microscopy and culture in the PERCH 
study. A specific objective was to determine whether sputum 
culture results should be included in the primary etiology anal-
ysis of the study. Other companion articles in this supplement 
focus on the agreement of polymerase chain reaction results 
between induced sputum and nasopharyngeal/oropharyngeal 
specimens, safety of induced sputum collection, and utility of 
induced sputum for diagnosing tuberculosis [18–20].
METHODS
Participants
Participants were children aged 1–59 months who were hos-
pitalized with World Health Organization (WHO)–defined 
severe or very severe pneumonia as part of the PERCH 
case-control study, details of which have been described else-
where [21, 22].
Chest Radiography
Chest radiographs (CXRs) from each child were interpreted by 
a panel of radiologists and pediatricians trained in the stand-
ardized interpretation of pediatric CXRs [23]. CXRs were 
classified as demonstrating consolidation, other infiltrate, 
both consolidation and other infiltrate, or as being normal or 
uninterpretable.
Specimen Collection
Induced sputum was obtained from cases at enrollment as 
described in detail in an accompanying article [17].
Laboratory Methods
Gram stain smears were made from the most visually purulent 
portion of each induced sputum specimen. The quality of sputum 
was assessed microscopically as outlined elsewhere [17], and only 
specimens with <10 SECs per (100×) low-power field (LPF) were 
included in further analyses. Microorganisms seen in the smear 
under (1000×) high power were described according to classic 
Gram stain morphotypes, and relative numbers of each type were 
recorded within the following categories: 1 (scanty), 2–9 (1+), 
10–99 (2+), ≥100 (3+) per representative high-power field.
The most purulent portion of each specimen was inoculated 
onto sheep or horse blood, chocolate, and MacConkey agars; 
streaked out using a standard 4-quadrant streaking method; 
and incubated at 35°C for 48 hours. Cultures were examined at 
24 hours and 48 hours, and predominant organisms were iden-
tified and quantified according to the furthest quadrant with 
visible colonies (first quadrant = scanty; second quadrant = 1+; 
third quadrant = 2+; fourth quadrant = 3+).
In order to standardize reporting across sites, uniform stand-
ard operating procedures, on-site training, and internal and 
external quality checks were established [24].
Study Definitions The following definitions were used in the 
study. 
Sputum Culture Positivity. Sputum culture results can be 
interpreted in a variety of ways and no one consistent approach 
is used by diagnostic laboratories. In general, it is recommended 
that potential pathogens must be present as a predominant iso-
late, usually with a compatible Gram stain appearance [25, 26]. 
For the interpretative criteria used in this study, we reported 
separately both organisms cultured in any amount and organ-
isms cultured as the predominant isolate with compatible Gram 
stain morphotype seen on microscopy.
CXR+ Cases and Nonpneumonia Cases. CXR+ pneumonia was 
defined by the presence of consolidation and/or other infiltrate on 
CXR [23]. Given that WHO-defined severe or very severe pneu-
monia has poor specificity for CXR+ pneumonia, a proportion of 
the enrolled cases likely did not have true pneumonia. Using base-
line clinical and laboratory characteristics and the absence of CXR 
changes, a group of “control” children unlikely to have pneumo-
nia (nonpneumonia) were identified. Children who met all of the 
following 3 criteria were defined as “nonpneumonia”: presence of 
a normal CXR, negative blood cultures, either normal respiratory 
rate or nonhypoxic in the absence of crackles or normal respira-
tory rate and nonhypoxic in the presence of crackles. We compared 
pneumonia to nonpneumonia cases for all analyses.
Prior Antimicrobial Therapy. Prior antimicrobial therapy 
was defined as antibiotic activity in serum by bioassay or docu-
mentation of antibiotic administration before induced sputum 
sample collection [27].
Microbiologically Confirmed Cases. Cases were defined as 
having microbiologically confirmed pneumonia if they had a 
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bacterium that was not regarded as a contaminant isolated from 
blood, lung aspirate, or pleural fluid [27].
Statistical Analyses
We hypothesized that pneumonia pathogens are more likely to 
be detected in sputum samples from children with radiographic 
pneumonia compared to sputum samples from children in the 
nonpneumonia group. Also, we hypothesized that pathogens 
that cause pneumonia are likely to be present in high enough 
quantities that they should be detected by both culture and 
microscopy, and thus pediatric induced sputum cultures should 
be interpreted in conjunction with Gram stain findings.
To assess whether pathogen detection was associated with 
CXR+ pneumonia among hospitalized infants and young chil-
dren, we calculated the prevalence of specific bacteria cultured 
from high-quality induced sputum specimens from CXR+ cases 
and nonpneumonia cases, stratified by site and prior antimicro-
bial therapy. Comparisons were made using the χ2 test. Odds 
ratios were calculated for associations of pneumonia status with 
organism presence using different interpretive criteria in order to 
examine the effect of Gram stain results on observed associations.
Ethical Considerations
The institutional review board or ethical review committee at 
each study site institution and at the Johns Hopkins Bloomberg 
School of Public Health approved the PERCH study protocol. 
Parents or guardians of participants provided written informed 
consent.
RESULTS
Induced sputum culture results were available for analysis from 
3772 (89.1%) of 4232 children enrolled in PERCH. Sputum 
from 2608 (69.1%) met the quality criterion of <10 SECs per 
LPF; of these, 1162 (44.6%) had radiographic pneumonia, 398 
(15.3%) were nonpneumonia cases, and 1048 (40.2%) did not 
meet either definition.
Of the 1162 CXR+ cases with high-quality induced spu-
tum, 866 (74.5%) had severe pneumonia and 296 (25.5%) had 
very severe pneumonia. A total of 197 (17.0%) were from the 
Gambia, 126 (10.8%) from Mali, 233 (20.1%) from Kenya, 
194 (16.7%) from Zambia, 198 (17.0%) from South Africa, 
142 (12.2%) from Bangladesh, and 72 (6.2%) from Thailand. 
The median age of these children was 8 months (interquartile 
Table 2. Prevalence of Bacteria Cultured in Any Quantity From High-Quality Induced Sputum Among Radiographic Pneumonia Cases and Nonpneumonia 
Cases, by Antibiotic Exposure Status
Regardless of Antibiotic Exposurea No Antibiotic Exposure Antibiotic Exposure
Bacteria
CXR+b (N = 1162) 
n (%)
Nonpneumoniac 
(N = 398) n (%) P Valued
CXR+ 
(N = 219)  
n (%)
Nonpneumonia 
(N = 124) n (%) P Value
CXR+ 
(N = 908) 
n (%)
Nonpneumonia 
(N = 266) n (%) P Value
Streptococcus 
pneumoniae
366 (31.5) 149 (37.4) .03 141 (64.4) 76 (61.3) .64 210 (23.1) 68 (25.6) .41
Staphylococcus aureus 94 (8.1) 27 (6.8) .45 13 (5.9) 12 (9.7) .20 80 (8.8) 15 (5.6) .10
Other streptococci and 
enterococcie
7 (0.6) 3 (0.8) .72 2 (0.9) 2 (1.6) .62 4 (0.4) 1 (0.4) >.99
Haemophilus influenzae 473 (40.7) 168 (42.2) .60 148 (67.6) 84 (67.7) >.99 302 (33.3) 77 (28.9) .21
Moraxella catarrhalis 363 (31.2) 156 (39.2) .005 111 (50.7) 55 (44.4) .26 238 (26.2) 96 (36.1) .002
Enterobacteriaceaef
All 103 (8.9) 33 (8.3) .76 12 (5.5) 5 (4.0) .62 89 (9.8) 27 (10.2) .91
Klebsiella pneumoniae 55 (4.7) 15 (3.8) .49 4 (1.8) 3 (2.4) .71 50 (5.5) 12 (4.5) .64
Mixed gram-negative 
rods
42 (3.6) 8 (2.0) .14 12 (5.5) 1 (0.8) .04 28 (3.1) 7 (2.6) .84
Other nonfermentative gram-negative rodsg
All 27 (2.3) 11 (2.8) .58 1 (0.5) 2 (1.6) .30 26 (2.9) 9 (3.4) .68
Pseudomonas aeruginosa 5 (0.4) 3 (0.8) .43 0 (0.0) 0 (0.0) N/A 5 (0.6) 3 (1.1) .39
High-quality induced sputum defined as <10 epithelial cells per low-power field.
Abbreviation: CXR, chest radiograph.
aPrior use of antibiotics defined as bioassay positive, antibiotic administration at the referral facility, antibiotic administration prior to induced sputum specimen collection at the study facility.
bRadiographic pneumonia (CXR+) defined as any abnormal CXR (consolidation and/or other infiltrates).
cNonpneumonia case defined as a case with a normal CXR, blood culture pathogen negative, and normal respiratory rate or nonhypoxic in the absence of crackles, or normal respiratory 
rate and nonhypoxic in the presence of crackles.
dP value from χ2 or Fisher exact test.
eOther streptococci and enterococci includes Streptococci (other than S. pneumoniae) and Enterococci species.
fEnterobacteriaceae includes Escherichia coli, Enterobacter species, Klebsiella species, Citrobacter species, and Serratia species, excluding mixed gram-negative rods. Klebsiella pneumo-
niae also reported separately.
gOther nonfermentative gram-negative rods include Pseudomonas aeruginosa, Acinetobacter species, Pseudomonas species. Pseudomonas aeruginosa also reported separately.
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range, 4–17), 493 (42.4%) were female, and 90 (7.8%) had 
human immunodeficiency virus infection. Among this group, 
908 (80.6%) had prior antimicrobial therapy before collection 
of induced sputum, although the frequency varied by site 
as follows: 43 (21.8%) at the Gambia, 112 (88.9%) at Mali, 
213 (91.4%) at Kenya, 190 (97.9%) at Zambia, 178 (89.9%) 
at South Africa, 104 (73.2%) at Bangladesh, and 68 (94.4%) 
at Thailand.
Of the 398 nonpneumonia cases, 67 (16.8%) were from the 
Gambia, 50 (12.6%) from Mali, 157 (39.5%) from Kenya, 48 
(12.1%) from Zambia, 22 (5.5%) from South Africa, 28 (7.0%) 
from Bangladesh, and 26 (6.5%) from Thailand. Relative to 
the CXR+ cases, the nonpneumonia cases were slightly older 
(median age 10 months; interquartile range, 3–20), less likely 
to be female (34.4%), and less likely to have human immuno-
deficiency virus (1.0%) infection or to have evidence of prior 
antimicrobial use (68.2%).
Table  1 shows the prevalence of bacteria cultured from 
induced sputum samples with <10 SECs per LPF from CXR+ 
cases, by study site, using the 2 culture interpretative criteria 
(ie, organisms cultured in any amount and organisms cultured 
as the predominant isolate with compatible Gram stain mor-
photype). Tables 2 and 3 show the prevalence of organisms 
cultured from both CXR+ and nonpneumonia cases using 
the 2 culture interpretative criteria, by antibiotic exposure sta-
tus. Haemophilus influenzae, Streptococcus pneumoniae, and 
Moraxella catarrhalis were the predominant organisms isolated 
when measured as organism detected in any amount (Table 2) 
or as the predominant organism (Table 3); their prevalence was 
similar in CXR+ and nonpneumonia cases. Klebsiella pneu-
moniae was more commonly isolated from cases from South 
Africa and Zambia, although this regional predominance was 
less evident when the more rigorous interpretative criterion 
(predominant organisms with compatible Gram stain morpho-
type) was used (Table 1). There was no predominant organism 
in 323 (27.8%) high-quality induced sputum specimens from 
cases with radiographic pneumonia.
Table  4 shows the organisms cultured from high-quality 
induced sputum samples from the cases with microbiologi-
cally confirmed pneumonia. The same organism was isolated 
from a normally sterile site and induced sputum in a minor-
ity of these cases overall; the exception being M. catarrhalis 
Table 3. Prevalence of Bacteria Cultured as the Predominant Organism With Compatible Gram Stain From High-Quality Induced Sputum Among 
Radiographic Pneumonia Cases and Nonpneumonia Cases, by Antibiotic Exposure Status
Regardless of Antibiotic Exposurea No Antibiotic Exposure Antibiotic Exposure
Bacteria
CXR+b 
(N = 1162) 
n (%)
Nonpneumoniac 
(N = 398) n (%) P Valued
CXR+ 
(N = 219)  
n (%)
Nonpneumonia 
(N = 124) n (%) P Value
CXR+ 
(N = 908) 
n (%)
Nonpneumonia 
(N = 266) n (%) P Value
Streptococcus 
pneumoniae
240 (20.7) 94 (23.6) .23 90 (41.1) 55 (44.4) .57 139 (15.3) 37 (13.9) .63
Staphylococcus aureus 29 (2.5) 9 (2.3) >.99 3 (1.4) 4 (3.2) .26 26 (2.9) 5 (1.9) .52
Other streptococci and 
enterococcie
5 (0.4) 2 (0.5) >.99 2 (0.9) 1 (0.8) >.99 3 (0.3) 1 (0.4) >.99
Haemophilus influenzae 262 (22.5) 92 (23.1) .84 104 (47.5) 60 (48.4) .91 141 (15.5) 27 (10.2) .03
Moraxella catarrhalis 215 (18.5) 93 (23.4) .04 62 (28.3) 29 (23.4) .37 147 (16.2) 61 (22.9) .01
Enterobacteriaceaef
All 34 (2.9) 11 (2.8) >.99 1 (0.5) 1 (0.8) >.99 32 (3.5) 10 (3.8) .85
Klebsiella pneumoniae 19 (1.6) 6 (1.5) >.99 1 (0.5) 0 (0.0) >.99 17 (1.9) 6 (2.3) .62
Mixed gram-negative 
rods
16 (1.4) 2 (0.5) .27 2 (0.9) 0 (0.0) .54 12 (1.3) 2 (0.8) .75
Other nonfermentative gram-negative rodsg
All 8 (0.7) 7 (1.8) .07 0 (0.0) 2 (1.6) .13 8 (0.9) 5 (1.9) .19
Pseudomonas 
aeruginosa
4 (0.3) 3 (0.8) .38 0 (0.0) 0 (0.0) N/A 4 (0.4) 3 (1.1) .20
High-quality induced sputum defined as <10 epithelial cells per low-power field.
Abbreviation: CXR, chest radiograph.
aPrior use of antibiotics defined as bioassay positive, antibiotic administration at the referral facility, antibiotic administration prior to induced sputum specimen collection at the study facility.
bRadiographic pneumonia (CXR+) defined as any abnormal CXR (consolidation and/or other infiltrates).
cNonpneumonia case defined as a case with a normal CXR, blood culture pathogen negative, and normal respiratory rate or nonhypoxic in the absence of crackles, or normal respiratory 
rate and nonhypoxic in the presence of crackles.
dP value from χ2 or Fisher exact test.
eOther streptococci and enterococci includes Streptococci (other than S. pneumoniae) and Enterococci species.
fEnterobacteriaceae includes Escherichia coli, Enterobacter species, Klebsiella species, Citrobacter species, and Serratia species, excluding mixed gram-negative rods. Klebsiella pneumo-
niae also reported separately.
gOther nonfermentative gram-negative rods include Pseudomonas aeruginosa, Acinetobacter species, Pseudomonas species. Pseudomonas aeruginosa also reported separately.
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for which 4 of 5 cases with positive cultures from a normally 
sterile site also had this organism isolated from induced 
sputum.
Table 5 shows the odds ratios associated with CXR+ case 
status for detection of the major potential pathogen group-
ings in induced sputum with varying culture interpretative 
criteria. For all organisms there was either no association or a 
negative association between CXR+ pneumonia and the iso-
lation of a pathogenic organism from induced sputum. For 
all organisms there was either no association or a negative 
association with the isolation of a pathogenic organism from 
induced sputum and CXR+ pneumonia (Table 5). This pat-
tern was consistent across all levels of interpretative criteria 
(Supplementary Table 1).
None of the reported findings changed when another, more 
rigorous, sputum culture interpretative criterion was used, 
namely, requiring that organisms be isolated in quantities of 
2+ or 3+, with or without compatible Gram stain appearance.
DISCUSSION
The key finding of this study is that culture of a potential patho-
gen from induced sputum was not clearly associated with radi-
ographic pneumonia in young children compared to a group of 
hospitalized children unlikely to have pneumonia, even when a 
sputum quality standard was applied.
When sputum culture is used in pneumonia etiology studies, 
predefined criteria have been traditionally used to determine 
results thought to be associated with pneumonia causation [11, 
13, 28, 29]. Only high-quality specimens that contain low num-
bers of SECs are typically accepted for analysis, and potential 
pathogens are required to be present as a predominant isolate, 
usually with a compatible Gram stain appearance [25, 26]. 
These criteria are derived from expert opinion, and their use-
fulness has been regularly debated [3–7, 30]. Had we applied 
this traditional approach to using sputum culture results in the 
PERCH study, the prevalence data shown in the second column 
of Table 3 would have been simply incorporated into the main 
etiologic analysis without further scrutiny. However, there was 
sufficient concern about the reliability of this approach with 
pediatric induced sputum specimens that we sought additional 
evidence of diagnostic utility.
Without a suitable comparator gold standard, it is difficult 
to determine the diagnostic accuracy of sputum culture for 
identifying pneumonia etiology. In this study, we compared 
cases of CXR+ pneumonia with a group of patients who 
(despite fulfilling the WHO case definition for severe or very 
severe pneumonia) were unlikely to have pneumonia. This 
approach is based on the assumption that true bacterial pneu-
monia pathogens will be overrepresented in induced sputa 
from children with CXR+ pneumonia compared to children 
unlikely to have pneumonia. We found no clear association 
between positive sputum culture results and pneumonia Ta
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status. Indeed, for S. pneumoniae and M. catarrhalis, micro-
organisms that can also be part of the normal oropharyngeal 
flora, isolation tended to be associated with nonpneumonia 
status, especially in the absence of a compatible Gram stain 
smear. In addition, among children with microbiologically 
confirmed pneumonia, culture of induced sputum often 
detected a different organism than that detected from the 
sterile-site culture. While it is certainly possible that some of 
these children had polymicrobial pneumonia, this finding fur-
ther highlights concerns about the nonspecificity of induced 
sputum culture in this age group, even when restricted to 
high-quality specimens that meet a rigorous definition of cul-
ture positivity. It may be possible that induced sputum does 
not adequately capture what is in the lung and/or that there is 
inevitable contamination with oropharyngeal flora that com-
promises even high-quality sputum.
It is standard laboratory practice to interpret sputum culture 
results in conjunction with the Gram stain smear of the same 
specimen [25, 26]. This follows the principle that, in general, an 
organism that acts as a pathogen rather than as a colonizer will 
be present in sufficient quantity to be seen on direct microscopy 
as well as to be detected by culture. Greater significance is given 
to organisms that grow in large amounts and are seen in the 
Gram stain. Despite a trend for the odds ratios of most organ-
isms associated with CXR+ pneumonia to be higher when there 
was a compatible Gram stain compared to when there was not, 
this did not alter the fact that no culture results were associated 
with radiographic pneumonia.
This study has several limitations. Most importantly, the 
alternative diagnoses in the nonpneumonia cases (all of whom 
had respiratory symptoms) were largely unknown and there 
is residual uncertainty about the appropriateness of using this 
group as a comparator. It is possible that a large proportion 
of these cases actually did have pneumonia that was yet to 
be detected radiographically and that the lack of association 
between sputum culture results and pneumonia may simply 
indicate misclassification of “nonpneumonia” episodes. Also, 
nonpneumonia cases were not equally represented across sites 
[20]. In addition, about three quarters of cases had received 
antibiotics before collection of induced sputum, and isolation 
of potential pathogens in specimens from these children was 
less common than in those who had not received antibiotics. 
We may not have had the statistical power to detect associa-
tions with case status in those who did not receive antibiotics 
given the relatively smaller number in this group. We were also 
reliant on an imperfect definition of prior antibiotic use that 
may have failed to identify all the cases who had received anti-
biotics [27]. Another potential limitation is interobserver var-
iability in reporting microscopy and culture results. However, 
uniform standard operating procedures, on-site training, and 
Table 5. Odds Ratio Associated With Radiographic Pneumonia Case (N = 1162) Versus Nonpneumonia Case (Reference) (N = 398) as a Predictor of 
Organism Presence Among Cases With High-Quality Induced Sputum Samples
Haemophilus influenzae
Streptococcus 
pneumoniae Staphylococcus aureus Moraxella catarrhalis
Other Gram-Negative 
Rodsa
Sputum Culture 
Interpretative Criteria
OR  
(95% CI)
P  
Value
OR  
(95% CI)
P  
Value
OR  
(95% CI)
P  
Value
OR  
(95% CI)
P  
Value
OR  
(95% CI)
P  
Value
Present in any 
quantity
0.94 (0.75,1.18) .60 0.77b (0.61,0.97) .03 1.21 (0.78,1.89) .40 0.69b (0.54,0.87) <.01 1.61 (0.91,2.85) .10
Present in any quan-
tity with compatible 
Gram stain
0.98 (0.76,1.26) .87 0.86 (0.67,1.1) .22 0.97 (0.51,1.85) .94 0.72b (0.55,0.93) <.01 1.38 (0.66,2.89) .39
Present in any 
quantity without 
compatible Gram 
stain
0.91 (0.65,1.27) .57 0.62b (0.4,0.98) .04 1.41 (0.78,2.57) .25 0.77 (0.52,1.13) .18 1.91 (0.79,4.59) .15
Predominant 
organism
0.91 (0.72,1.16) .46 0.73b (0.57,0.94) <.01 1.19 (0.72,1.96) .50 0.67b (0.52,0.86) <.01 1.42 (0.73,2.77) .31
Predominant organ-
ism with compati-
ble Gram stain
0.97 (0.74,1.27) .81 0.84b (0.64,1.1) .21 1.11 (0.52,2.36) .79 0.72b (0.55,0.95) .02 1.26 (0.51,3.13) .62
Predominant 
organism without 
compatible Gram 
stain
0.86 (0.61,1.23) .42 0.51b (0.31,0.83) <.01 1.24 (0.65,2.37) .52 0.68 (0.45,1.04) .07 1.59 (0.6,4.2) .35
Abbreviations: CI, confidence interval; OR, odds ratio. 
High-quality induced sputum defined as <10 epithelial cells per low-power field. Radiographic pneumonia (CXR+) defined as any abnormal chest radiograph (CXR) (consolidation and/or other 
infiltrates). Nonpneumonia case defined as a case with a normal CXR, blood culture pathogen negative, and normal respiratory rate or nonhypoxic in the absence of crackles, or normal 
respiratory rate and nonhypoxic in the presence of crackles.
aOther nonfermentative gram-negative rods include Pseudomonas aeruginosa, Acinetobacter species, Pseudomonas species.
bP < .05.
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internal and external quality checks were incorporated into the 
PERCH study in an effort to standardize reporting across sites, 
and quality reviews indicated that these procedures were being 
followed in a consistent manner [24]. Despite these efforts to 
standardize methods and to collect all relevant data, there is 
still a subjective element to sputum culture interpretation that 
may not have been captured by the variables collected and used 
in the analyses.
In summary, isolation of bacteria from induced sputum did 
not reflect CXR+ pneumonia in young children hospitalized 
with WHO-defined severe or very severe radiographic pneu-
monia. Despite potential confounding by antibiotic use and 
the limitations of the study design, these findings did not pro-
vide sufficient evidence to incorporate induced sputum cul-
ture results into the primary etiology analysis of the PERCH 
study. Furthermore, the findings of this study do not support 
the culture of induced sputum specimens as a diagnostic tool 
for pneumonia in young children as part of routine clinical 
practice.
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